or Try an Advanced Search...

    Technical Analysis for IQV - IQVIA Holdings, Inc.

    Grade Last Price % Change Price Change
    D 208.49 -1.40% -2.95
    IQV closed down 1.4 percent on Monday, July 1, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IQV trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Volume Surge Other -1.40%
    Older End-of-Day Signals for IQV ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 8 hours ago
    Lower Bollinger Band Support about 8 hours ago
    Fell Below Lower Bollinger Band about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    20 DMA Resistance about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IQV Chart by TradingView
    Basic chart:

    Profile

    IQVIA Holdings, Inc. Description

    IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

    Is IQV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Clinical Development Expertise Aids IQVIA (IQV), Costs High
    Jun 30 Investors in IQVIA Holdings (NYSE:IQV) have seen respectable returns of 31% over the past five years
    Jun 25 Insiders At IQVIA Holdings Sold US$9.2m In Stock, Alluding To Potential Weakness
    Jun 25 IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award "Best Use of Artificial Intelligence in Healthcare"
    Jun 21 Paychex (PAYX) to Report Q4 Earnings: What's in the Offing?
    Jun 18 ‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
    Jun 18 Ranking the top ten clinical research organisations in the world
    Jun 13 IQVIA (IQV) Announces Launch of Trial Technology Platform
    Jun 13 IQVIA introduces new trial technology platform for research sites
    Jun 12 IQVIA Launches "One Home" Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
    See more IQV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 261.73
    52 Week Low 167.42
    Average Volume 1,206,369
    200-Day Moving Average 220.72
    50-Day Moving Average 223.80
    20-Day Moving Average 214.69
    10-Day Moving Average 212.60
    Average True Range 4.66
    RSI (14) 32.43
    ADX 24.33
    +DI 18.16
    -DI 26.22
    Chandelier Exit (Long, 3 ATRs) 211.65
    Chandelier Exit (Short, 3 ATRs) 222.01
    Upper Bollinger Bands 220.68
    Lower Bollinger Band 208.70
    Percent B (%b) -0.02
    BandWidth 5.58
    MACD Line -3.93
    MACD Signal Line -3.96
    MACD Histogram 0.0298
    Fundamentals Value
    Market Cap 38.05 Billion
    Num Shares 183 Million
    EPS 5.96
    Price-to-Earnings (P/E) Ratio 34.98
    Price-to-Sales 2.68
    Price-to-Book 6.86
    PEG Ratio 1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 218.59
    Resistance 3 (R3) 219.55 217.16 216.90
    Resistance 2 (R2) 217.16 214.59 216.67 216.34
    Resistance 1 (R1) 212.82 213.00 211.63 211.86 215.78
    Pivot Point 210.43 210.43 209.83 209.94 210.43
    Support 1 (S1) 206.09 207.86 204.90 205.13 201.20
    Support 2 (S2) 203.70 206.27 203.21 200.64
    Support 3 (S3) 199.36 203.70 200.08
    Support 4 (S4) 198.40